The purpose of this study is to evaluate the effects induced by the cholesterol-reducing drug
Lovastatin on the platelet proteome of healthy volunteers. Our results may allow to recognize
the cell signalling modifications induced by Lovastatin. Furthermore, the current study aims
to characterize the biological and inter-individual variation of platelet's proteome as
measured by liquid chromatography-tandem mass spectrometry. Lastly, the exploration of
changes induced by Lovastatin on the platelet's proteome may allow the discovery of
modifications relative to the effects of statins on hemostasis and the lipid profile.